Financial Advisory Service, Inc. Exact Sciences Corp Transaction History

Financial Advisory Service, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$47.19 - $70.77 $141,570 - $212,310	3,000 New	3,000 $203,000
Q2 2022 Aug 02, 2022	SELL	$35.61 - $76.23 $106,830 - $228,690	-3,000 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$72.5 - $100.68 $507 - $704	-7 Reduced 0.23%	3,000 $233,000
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $631 - $868	7 Added 0.23%	3,007 $287,000
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $87,427 - $116,257	-750 Reduced 20.0%	3,000 $395,000
Q1 2020 May 14, 2020	BUY	$37.9 - $104.44 $47,375 - $130,550	1,250 Added 50.0%	3,750 $218,000
Q1 2019 May 13, 2019	SELL	$61.98 - $96.5 $154,950 - $241,250	-2,500 Reduced 50.0%	2,500 $217,000
Q1 2018 May 02, 2018	SELL	$39.82 - $57.53 $119,460 - $172,590	-3,000 Reduced 37.5%	5,000 $202,000
Q4 2017 Jan 29, 2018	SELL	$46.49 - $60.51 $92,980 - $121,020	-2,000 Reduced 20.0%	8,000 $420,000
Q3 2017 Oct 19, 2017	BUY	$37.05 - $47.12 $370,500 - $471,200	10,000	10,000 $471,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Financial Advisory Service, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Advisory Service, Inc. with notifications on news.